Sodium Oligomannate for Alzheimer's Disease
An Efficacy and Safety Study of Sodium Oligomannate (GV-971) for the Treatment of Alzheimer's Disease
- Age
- 50 – 85
- Sex
- Any
- Trial phase
- Phase 4
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 1,312 (estimated)
- Sponsor
- Green Valley (Shanghai) Pharmaceuticals Co., Ltd. · Industry
This trial is looking for people with mild to moderate Alzheimer's disease to see if sodium oligomannate is effective and safe for long-term use. Participants will need to meet specific health criteria and will be monitored for any side effects during the study.
You may be able to join if
- I have mild to moderate Alzheimer's disease.
- I have had a decline in cognitive and functional abilities for at least 1 year.
- My test score is between 11 and 24.
- My Hachinski Ischemic Score is 4 or less.
- My depression rating score is 10 or less.
- I have an MRI that supports an Alzheimer's diagnosis.
- I have a reliable study partner or caregiver.
- I can sign the informed consent form.
You may not be able to join if
- I have a different type of dementia.
- I have major brain disease shown in an MRI.
- My resting heart rate is less than 50 beats per minute.
- I have had a major medical illness or unstable condition in the past year.
- I have taken certain Alzheimer's medications in the last 6 months.
- I have inadequate liver function.
- I have inadequate organ function.
- My ECG shows significant abnormalities.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your EligibilityThe primary purpose of this study is to confirm the clinical efficacy and mechanism of action of GV-971, and identify incidence of known adverse reactions in long-term use and observe new adverse reactions, providing more guidance for clinical use.
Loading trial locations…